F. Qiu

A multicentre single arm phase 2 trial of neoadjuvant pyrotinib and letrozole plus dalpiciclib for triple-positive breast cancer

Xinyu Zheng, G. Jerusalem, Tong Liu, 2022, Nature Communications.

LINC00982 Inhibits the Proliferation, Migration, and Invasion of Breast Cancer Cells Through the miR-765/DPF3 Axis.

F. Chi, Sijia Han, Guijin He, 2022, DNA and cell biology.

The long non-coding RNA HOTTIP promotes breast cancer cell migration, invasion, and epithelial-mesenchymal transition via Wnt/β-catenin pathway.

Zhen Liu, Fei Xing, Zhen Liu, 2019, Biochemistry and cell biology = Biochimie et biologie cellulaire.

Clinical and imaging characteristics of breast ductal carcinoma in situ with microinvasion.

F. Xing, Sijia Han, Yong-qing Xu, 2020, Journal of applied clinical medical physics.

CircRNA_100395 protects breast carcinoma deterioration by targeting MAPK6.

S-J. Han, F. Xing, H. Yu, 2020, European Review for Medical and Pharmacological Sciences.

A pilot trial of neoadjuvant pyrotinib plus trastuzumab, dalpiciclib, and letrozole for triple‐positive breast cancer

M. Tang, Guanglei Chen, Jinqi Xue, 2024, MedComm.